Skip to main content

Advertisement

SpringerLink
Log in

Transcatheter Pulmonary Valve Replacement: Current State of Art

  • Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The past couple of decades have brought tremendous advances to the field of pediatric and adult congenital heart disease (CHD). Percutaneous valve interventions are now a cornerstone of not just the congenital cardiologist treating patients with congenital heart disease, but also—and numerically more importantly—for adult interventional cardiologists treating patients with acquired heart valve disease. Transcatheter pulmonary valve replacement (tPVR) is one of the most exciting recent developments in the treatment of CHD and has evolved to become an attractive alternative to surgery in patients with right ventricular outflow tract (RVOT) dysfunction. This review aims to summarize (1) the current state of the art for tPVR, (2) the expanding indications, and (3) the technological obstacles to optimizing tPVR.

Recent Findings

Since its introduction in 2000, more than ten thousands tPVR procedures have been performed worldwide. Although the indications for tPVR have been adapted earlier from those accepted for surgical intervention, they remain incompletely defined. The new imaging modalities give better assessment of cardiac anatomy and function and determine candidacy for the procedure. The procedure has been shown to be feasible and safe when performed in patients who received pulmonary conduit and or bioprosthetic valves between the right ventricle and the pulmonary artery. Fewer selected patients post trans-annular patch repair for tetralogy of Fallot may also be candidates for this technology. Size restrictions of the currently available valves limit deployment in the majority of patients post trans-annular patch repair. Newer valves and techniques are being developed that may help such patients.

Summary

Refinements and further developments of this procedure hold promise for the extension of this technology to other patient populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance, •• Of major importance

  1. Verheugt CL, Uiterwaal C, van der Velde ET, Meijoom FJ, Pieper PG, van Dijk AP, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31:1220–9.

    Article  PubMed  Google Scholar 

  2. Ong K, Boone R, Gao M, Carere R, Webb J, Kiess M, et al. Right ventricle to pulmonary artery conduit reoperations in patients with tetralogy of fallot or pulmonary atresia associated with ventricular septal defect. Am J Cardiol. 2013;111(11):1638–43.

    Article  PubMed  Google Scholar 

  3. Boethig D, Thies WR, Hecker H, Breymann T. Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and Contegras. Eur J Cardiothorac Surg. 2005;27(1):58–66.

    Article  PubMed  Google Scholar 

  4. Elahi M, Dhannapuneni R, Firmin R, Hickey M. Direct complications of repeat median sternotomy in adults. Asian Cardiovasc Thorac Ann. 2005;13(2):135–8.

    Article  PubMed  Google Scholar 

  5. Temeck BK, Katz NM, Wallace RB. An approach to reoperative median sternotomy. J Card Surg. 1990;5(1):14–25.

    Article  CAS  PubMed  Google Scholar 

  6. Daebritz SH. Update in adult congenital cardiac surgery. Pediatr Cardiol. 2007;28(2):96–104.

    Article  PubMed  Google Scholar 

  7. van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011;8(1):50–60.

    Article  PubMed  Google Scholar 

  8. Vida VL, Berggren H, Brawn WJ, Daenen W, Di Carlo D, Di Donato R, et al. Risk of surgery for congenital heart disease in the adult: a multi-centered European study. Ann Thorac Surg. 2007;83(1):161–8.

    Article  PubMed  Google Scholar 

  9. Verheugt CL, Uiterwaal CS, Grobbee DE, Mudler BG. Long-term prognosis of congenital heart defects: a systematic review. Int J Cardiol. 2008;131(1):25–32.

    Article  PubMed  Google Scholar 

  10. Khairy P, Aboulhosn J, Gurvitz MZ, Opotowsky AR, Mongeon FP, Kay J, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010;122(9):868–75.

    Article  PubMed  Google Scholar 

  11. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–5.

    Article  CAS  PubMed  Google Scholar 

  12. Coats L, Tsang V, Khambadkone S, van Doorn C, Cullen S, Deanfield J, et al. The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention. Eur J Cardiothorac Surg. 2005;27(4):536–43.

    Article  PubMed  Google Scholar 

  13. Aboulhosn JA, Lluri G, Gurvitz MZ, Khairy P, Mongeon FP, Kay J, et al. Left and right ventricular diastolic function in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Can J Cardiol. 2013;29(7):866–72.

    Article  PubMed  Google Scholar 

  14. Fernandes FP, Manlhiot C, Roche SL, Grosse-Wortmann L, Slorach C, McCrindle BW, et al. Impaired left ventricular myocardial mechanics and their relation to pulmonary regurgitation, right ventricular enlargement and exercise capacity in asymptomatic children after repair of tetralogy of Fallot. J Am Soc Echocardiogr. 2012;25(5):494–503.

    Article  PubMed  Google Scholar 

  15. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al. Risk factor for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356(9234):975–81.

    Article  CAS  PubMed  Google Scholar 

  16. Filsoufi F, Anyanwu AC, Salzberg SP, Frankel T, Cohn LH, Adams DH. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg. 2005;80(3):845–50.

    Article  PubMed  Google Scholar 

  17. Garatti A, Nano G, Bruschi G, et al. Twenty-five year outcomes of tricuspid valve replacement comparing mechanical and biologic prostheses. Ann Thorac Surg. 2012;93(4):1146–53.

    Article  PubMed  Google Scholar 

  18. Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011;13:9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–57.

    Article  PubMed  Google Scholar 

  20. Silversides CK, Marelli A, Beauchesen L, Dore A, Kiess M, Salehian O, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol. 2010;26:143–50.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e143–263.

    Article  PubMed  Google Scholar 

  22. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with dysfunctional right ventricular outflow tract conduits: early results from the U.S. clinical trial. J Am Coll Cardiol. 2009;54:1722–9.

    Article  PubMed  Google Scholar 

  23. Borik S, Crean A, Horlick E, Osten M, Lee KJ, Chaturvedi R, et al. Percutaneous pulmonary valve implantation: 5 years of follow-up: does age influence outcomes? Circ Cardiovasc Interv. 2015;8(2):e001745.

    Article  PubMed  Google Scholar 

  24. Aboulhosn J, Levi DS. Percutaneous pulmonary valve implantation: is earlier valve implantation better? Circ Cardiovasc Interv. 2015;8(2):e002260.

    Article  PubMed  Google Scholar 

  25. Berman DP, McElhinney DB, Vincent JA, Hellenbrand WE, Zahn EM. Feasibility and short-term outcomes of percutaneous transcatheter pulmonary valve replacement in small (<30 kg) children with dysfunctional right ventricular outflow tract conduits. Circ Cardiovasc Interv. 2014;7:142–8.

    Article  PubMed  Google Scholar 

  26. McElhinney DB, Hellenbrand WE, Zahn EM, Jones TK, Cheatham JP, Lock JE, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122:507–16.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kenny D, Hijazi ZM, Kar S, Rhodes J, Mullen M, Makkar R, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58:2248–56.

    Article  PubMed  Google Scholar 

  28. Wadia SK, Kenny D, Alkashkari W, Matella T, Kavinsky CJ, Hijazi ZM. Extended application of self-fabricated covered stents for interventions in adults with congenital heart disease. J Struct Heart Dis. 2016;2(3):79–86.

    Article  Google Scholar 

  29. AlkashkariW, Cao QL, Kavinsky CJ, Hijazi ZM. Percutaneous pulmonary valve implantation for RVOT Defect. Cardiac Intervention Today. September/October 2010.

  30. AlBugami S, Althobaiti MW, Alrahemi J, Alsaiedi AJ, AlKashkari W. Coronary intervention of an anomalous left main coronary artery arising from the right sinus of valsalva presented as acute coronary syndrome. J Cardiol Curr Res. 2016;5(6):00184.

    Google Scholar 

  31. Morray BH, McElhinney DB, Cheatham JP, Zahn EM, Berman DP, Sullivan PM, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013;6(5):535–42.

    Article  PubMed  Google Scholar 

  32. Sridharan S, Coats L, Khambadkone S, Taylor AM, Bonhoeffer P. Images in cardiovascular medicine. Transcatheter right ventricular outflow tract intervention: the risk to the coronary circulation. Circulation. 2006;113(25):e934–5.

    Article  PubMed  Google Scholar 

  33. Biermann D, Schönebeck J, Rebel M, Weil J, Dodge-Khatami A. Left coronary artery occlusion after percutaneous pulmonary valve implantation. Ann Thorac Surg. 2012;94:e7–9.

    Article  PubMed  Google Scholar 

  34. McElhinney DB, Cheatham JP, Jones TK, Lock JE, Vincent JA, Zahn EM, et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv. 2011;4:602–14.

    Article  PubMed  Google Scholar 

  35. Alkashkari W, Balan P, Heitschmidt M, Kavnisky CJ, Hijazi ZM. Pre-closure of femoral venous access sites used for very large-sized sheath insertion with Perclose device in adults undergoing cardiac intervention. Catheter Cardiovasc Interv. 2010;76(1):S3–S36.

    Article  Google Scholar 

  36. McElhinney DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6(3):292–300.

    Article  PubMed  Google Scholar 

  37. Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112:1189–97.

    Article  PubMed  Google Scholar 

  38. • Cheatham JP, Hellenbrand WE, Zahn EM, Jones TK, Berman DP, Vincent JA, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation. 2015;131:1960–70. This study prove that tPVR with the Melody valve provided good hemodynamic and clinical outcomes up to 7 years after implantation Stent fracture was the most common cause of valve dysfunction.

    Article  PubMed  Google Scholar 

  39. Jones TK, Rome JJ, Armstrong AK, Berger F, Hellenbrand WE, Cabalka AK, et al. Transcatheter pulmonary valve replacement reduces tricuspid regurgitation in patients with right ventricular volume/pressure overload. J Am Coll Cardiol. 2016;68:1525–35.

    Article  PubMed  Google Scholar 

  40. Haas NA, Moysich A, Neudorf U, Mortezaeian H, Abdel-Wahab M, Schneider H, et al. Percutaneous implantation of the Edwards SAPIEN pulmonic valve: initial results in the first 22 patients. Clin Res Cardiol. 2013;102:119–28.

    Article  PubMed  Google Scholar 

  41. Wilson WM, Benson LN, Osten MD, Shah A, Horlick EM. Transcatheter pulmonary valve replacement with the Edwards Sapien system: the Toronto experience. JACC Cardiovasc Interv. 2015;8(14):1819–27.

    Article  PubMed  Google Scholar 

  42. Faza N, Kenny D, Kavinsky C, Amin Z, Heitschmidt M, Hijazi ZM. Single-center comparative outcomes of the Edwards SAPIEN and Medtronic Melody transcatheter heart valves in the pulmonary position. Catheter Cardiovasc Interv. 2013;82:E535–41.

    PubMed  Google Scholar 

  43. Chowdhury SM, Hijazi ZM, Rhodes J, et al. Early echocardiographic changes after percutaneous implantation of the Edwards SAPIEN transcatheter heart valve in the pulmonary position. Echocardiography. 2013;30:786–93.

    Article  PubMed  Google Scholar 

  44. Gatlin SW, Kim DW, Mahle WT. Cost analysis of percutaneous pulmonary valve replacement. Am J Cardiol. 2011;108(4):572–4. 574

  45. Raikou M, McGuire A, Lurz P, Bonhoeffer P, Wegmueller Y. An assessment of the cost of percutaneous pulmonary valve implantation (PPVI) versus surgical pulmonary valve replacement (PVR) in patients with right ventricular outflow tract dysfunction. J Med Econ. 2011;14(1):47­52.

    Article  PubMed  Google Scholar 

  46. McElhinney DB, Bergersen L, Marshall AC. In situ fracture of stents implanted for relief of pulmonary arterial stenosis in patients with congenitally malformed hearts. Cardiol Young. 2008;18:405–14.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Nordmeyer J, Khambadkone S, Coats L, Schievano S, Lurz P, Parenzan G, et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation. 2007;115(11):1392–7.

    Article  PubMed  Google Scholar 

  48. Nordmeyer J, Coats L, Lurz P, Lee TY, Derrick G, Rees P, et al. Percutaneous pulmonary valve-in-valve implantation: a successful treatment concept for early device failure. Eur Heart J. 2008;29:810–5.

    Article  PubMed  Google Scholar 

  49. Boudjemline Y, Malekzadeh-Milani S, Patel M, Thambo JB, Bonnet D, Iserin L, et al. Predictors and outcomes of right ventricular outflow tract conduit rupture during percutaneous pulmonary valve implantation: a multicentre study. EuroIntervention. 2016;11(9):1053–62.

    Article  PubMed  Google Scholar 

  50. Butera G, Milanesi O, Spadoni I, Piazza L, Donti A, Ricci C, et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Catheter Cardiovasc Interv. 2013;81(2):310–6.

    Article  PubMed  Google Scholar 

  51. Suradi HS, Hijazi ZM. Percutaneous pulmonary valve implantation. Glob Cardiol Sci Pract. 2015;2015(2):23. https://doi.org/10.5339/gcsp.2015.23.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Malekzadeh-Milani S, Ladouceur M, Patel M, Boughenou FM, Iserin L, Bonnet D, et al. Incidence and predictors of melody(R) valve endocarditis: a prospective study. Arch Cardiovasc Dis. 2015;108:97–106.

  53. Khanna AD, Hill KD, Pasquali SK, et al. Benchmark outcomes for pulmonary valve replacement using the society of thoracic surgeons databases. Ann Thoracic Surg. 2015;100:138–45.

    Article  Google Scholar 

  54. Feltes TF, Bacha E, Beekman RHIII, JCheatham JP, Feinstein JA, Gomes AS, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2607–52.

    Article  PubMed  Google Scholar 

  55. Boshoff DE, Cools BL, Heying R, Troost E, Kefer J, Budts W, et al. Off-label use of percutaneous pulmonary valved stents in the right ventricular outflow tract: time to rewrite the label? Catheter Cardiovasc Interv. 2013;81:987–95.

    Article  PubMed  Google Scholar 

  56. Schievano S, Coats L, Migliavacca F, Norman W, Frigiola A, Deanfield J, et al. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. J Cardiovas Magn Reson. 2007;9:687–95.

    Article  Google Scholar 

  57. Boudjemline Y, Brugada G, Van-Aerschot I, Patel M, Basquin A, Bonnet C, et al. Outcomes and safety of transcatheter pulmonary valve replacement in patients with large patched right ventricular outflow tracts. Arch Cardiovasc Dis. 2012;105:404–13.

    Article  PubMed  Google Scholar 

  58. Bertels RA, Blom NA, Schalij MJ. Edwards SAPIEN transcatheter heart valve in native pulmonary valve position. Heart. 2010;96:661.

    Article  CAS  PubMed  Google Scholar 

  59. Boudjemline Y, Agnoletti G, Bonnet D, Bonhoeffer P. Percutaneous pulmonary valve replacement in a large right ventricular outflow tract—an experimental study. J Am Coll Cardiol. 2004;43:1082–7.

    Article  PubMed  Google Scholar 

  60. Schievano S, Taylor AM, Capelli C, Coats L, Walker F, Lurz P, et al. First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. Eur Secur. 2010;5:745–50.

    Google Scholar 

  61. Benson LN. One year outcomes from the early feasibility study of the Harmony transcatheter pulmonary valve. Presented at TCT, 2016.

  62. Cao QL, Kenny D, Zhou D, Pan W, Guan L, Ge J, et al. Early clinical experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv. 2014;84:1131–7.

    Article  PubMed  Google Scholar 

  63. Promphan W, Prachasilchai P, Siripornpitak S, Qureshi SA, Layangool T. Percutaneous pulmonary valve implantation with the Venus P-valve: clinical experience and early results. Cardiol Young. 2015;19:1–13.

    Google Scholar 

  64. Garay F, Pan X, Zhang YJ, Wang C, Springmuller D. Early experience with the Venus p-valve for percutaneous pulmonary valve implantation in native outflow tract. Neth Heart J. 2017;25:76–8.

    Article  CAS  PubMed  Google Scholar 

  65. Husain J, Praichasilchai P, Gilbert Y, Qureshi SA, Morgan GJ. Early European experience with the Venus P-valve®: filling the gap in percutaneous pulmonary valve implantation. EuroIntervention. 2016;12(5):e643–51.

    Article  PubMed  Google Scholar 

  66. Kim GB, Kwon BS, Lim HG. First in human experience of a new self-expandable percutaneous pulmonary valve implantation using knitted nitinol-wire and tri-leaflet porcine pericardial valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv. 2017;89(5):906–9.

    Article  PubMed  Google Scholar 

  67. Gillespie MJ, Rome JJ, Levi DS, Williams RJ, Rhodes JF, Cheatham JP, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5:862–70.

    Article  PubMed  Google Scholar 

  68. Sosnowski C, Matella T, Fogg L, Ilbawi M, Nagaraj H, Kavinsky C, et al. Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: comparison with surgical PVR. Catheter Cardiovasc Interv. 2016;88:804–10.

    Article  PubMed  Google Scholar 

  69. Phillips ABM, Nevin P, Shah A, Shah A, Olshove V, Garg R, et al. Development of a novel hybrid strategy for transcatheter pulmonary valve placement in patients following transannular patch repair of tetralogy of Fallot. Catheter Cardiovasc Interv. 2016;87:403–10.

    Article  PubMed  Google Scholar 

  70. Wilhelm C, Swinning J, Sisk M, Holzer R. Melody valve implantation using a double-balloon “flower-blossom” technique. Cong Cardiol Today. 2014;8:1–8.

    Google Scholar 

  71. Violini R, Vairo U, Hijazi ZM. Stent strut breakage using high pressure balloons for bifurcation stenting and subsequent percutaneous pulmonary valve replacement using the Edwards Sapien THV. Catheter Cardiovasc Interv. 2013;82:834–7.

    Article  PubMed  Google Scholar 

  72. Maschietto N, Milanesi O. A concert in the heart: bilateral melody valve implantation in the branch pulmonary arteries. J Invasive Cardiol. 2013;25:E69–71.

    PubMed  Google Scholar 

  73. Jalal Z, Malekzadeh-Milani S, Hofbeck M, Al Najashi K, Thambo JB, Boudjemline Y. A new percutaneous pulmonary valve implantation technique for complex right ventricular outflow tracts: the “folded melody valve”. Catheter Cardiovasc Interv. 2015;85:604–10.

    Article  PubMed  Google Scholar 

  74. Levi DS, Sinha S, Salem MM, Aboulhosn JA. Transcatheter native pulmonary valve and tricuspid valve replacement with the sapien XT: initial experience and development of a new delivery platform. Catheter Cardiovasc Interv. 2016;88(3):434–43.

    Article  PubMed  Google Scholar 

  75. DeGiovann J. Transcatheter pulmonary valve replacement. The Edwards Sapien valve. Struct Heart Dis J. 2017;3:62–72.

    Article  Google Scholar 

  76. •• Tretter JT, Friedberg MK, Wald RM, McElhinney DB. Defining and refining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: contributions from anatomical and functional imaging. Int J Cardiol. 2016;221:916–25. This article provide other indices that can refine the timing of tPVR, such as indices of myocardial wall strain, tissue velocities, diastology, and ventricular response to exercise.

    Article  PubMed  Google Scholar 

  77. Armstrong AK, Balzer DT, Cabalka AK, Gray RG, Javois AJ, et al. One-year follow-up of the melody transcatheter pulmonary valve multicenter post-approval study. JACC Cardiovasc Interv. 2014;7:1254–62.

    Article  PubMed  Google Scholar 

  78. Eicken A, Ewert P, Hager A, Peters B, Fratz S, Kuehne T, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;32(10):1260–5.

    Article  PubMed  Google Scholar 

  79. Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117(15):1964–72.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. King Saud Bin Abdulaziz University For Health Science & King Faisal Cardiac Center, King Abdulaziz Medical City for National Guard, Jeddah, Saudi Arabia

    Wail Alkashkari & Amani Alsubei

  2. Sidra Cardiac Program, Sidra Medical & Research Center, Doha, Qatar

    Ziyad M. Hijazi

  3. Weill Cornell Medicine, New York, NY, USA

    Ziyad M. Hijazi

Authors
  1. Wail Alkashkari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amani Alsubei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ziyad M. Hijazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wail Alkashkari.

Ethics declarations

Conflict of Interest

Wail Alkashkari and Amani Alsubei declare that they have no conflict of interest.

Ziyad M. Hijazi is a consultant for Venus Medtech.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Structural Heart Disease

Electronic Supplementary Material

ESM 1

(DOCX 24kb).

ESM 2

(PPTX 1.14mb).

ESM 3

(PPTX 1.15mb).

ESM 4

(PPTX 3.38mb).

ESM 5

(PPTX 1.15mb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alkashkari, W., Alsubei, A. & Hijazi, Z.M. Transcatheter Pulmonary Valve Replacement: Current State of Art. Curr Cardiol Rep 20, 27 (2018). https://doi.org/10.1007/s11886-018-0966-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-018-0966-y

Keywords

Search

Navigation